Late and long-lasting response in an adult chronic idiopathic thrombocytopenic purpura after extended course of rituximab

Leuk Lymphoma. 2003 Mar;44(3):561-2. doi: 10.1080/1042819021000055020.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / immunology
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / surgery
  • Autoimmune Diseases / therapy*
  • B-Lymphocytes / immunology
  • Female
  • Humans
  • Immunotherapy*
  • Middle Aged
  • Prednisone / therapeutic use
  • Purpura, Thrombocytopenic / drug therapy
  • Purpura, Thrombocytopenic / surgery
  • Purpura, Thrombocytopenic / therapy*
  • Remission Induction
  • Rituximab
  • Splenectomy

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Rituximab
  • Prednisone